MEDICINOVA, INC.
MNOVCIK 0001226616
Revenue (TTM)
$1.44M
−59.0% YoY
Q1 May 2026
Net Income (TTM)
−$11.78M
−8.6% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.24
−4.3% YoY
Q1 May 2026
Gross Margin
100.0%
Q1 May 2026
Operating Margin
-901.5%
Q1 May 2026
Net Margin
-815.4%
Q1 May 2026
Free Cash Flow (TTM)
−$14.31M
Q1 May 2026
Cash
$27.33M
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
49.22M sh
Q1 May 2026